Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort

Our findings reveal that antidepressants and bladder antimuscarinic drugs consistently induce neurotoxicity and pathogenic amyloid-beta peptide secretion without affecting tau phosphorylation. Our study validates the direct correlation between increased dementia risk and the action of antidepressant and bladder antimuscarinic drugs and provides molecular insights into how these drugs induce neuronal dysfunction contributing to AD development.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70855_099906
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort

S. L. Gray, Tiara A. Schwarze‐Taufiq, Jessica E. Young, Katherine Hui et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort

S. L. Gray, Tiara A. Schwarze‐Taufiq, Jessica E. Young, Katherine Hui, Inez K.A. Pranoto, Paul K Crane
article en

Abstract

Our findings reveal that antidepressants and bladder antimuscarinic drugs consistently induce neurotoxicity and pathogenic amyloid-beta peptide secretion without affecting tau phosphorylation. Our study validates the direct correlation between increased dementia risk and the action of antidepressant and bladder antimuscarinic drugs and provides molecular insights into how these drugs induce neuronal dysfunction contributing to AD development.

Alzheimer s & DementiaVol. 21(S1)
Kaiser Permanente Washington Health Research Institute (US), California Institute for Regenerative Medicine (US), University of Washington (US)
Good health and well-being
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.